MYLAN 351
Pill imprint MYLAN 351 has been identified as Haloperidol 0.5 mg.
Haloperidol is used in the treatment of dementia; psychosis; nausea/vomiting; mania; tourette's syndrome (and more), and belongs to the drug class miscellaneous antipsychotic agents. Risk cannot be ruled out during pregnancy.
Haloperidol 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Haloperidol Images
- Imprint:
-
MYLAN 351
- Strength:
- 0.5 mg
- Color:
- Orange
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0351
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0733 | UDL Laboratories Inc |
| 18837-0348 | Innoviant Pharmacy Inc (repackager) |
| 68071-0494 | Nucare Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More Haloperidol resources
- Haloperidol (Wolters Kluwer)
- Haloperidol Decanoate (Wolters Kluwer)
- Haloperidol Solution (Wolters Kluwer)
- Haloperidol Tablets (Wolters Kluwer)
- haloperidol (Cerner Multum)
- Alti-Haloperidol (Micromedex) - Includes Dosage Information
- Apo-Haloperidol (Micromedex) - Includes Dosage Information
- Novo-Peridol (Micromedex) - Includes Dosage Information
- Peridol (Micromedex) - Includes Dosage Information
- Pms-Haloperidol (Micromedex) - Includes Dosage Information
- Ratio-Haloperidol (Micromedex) - Includes Dosage Information
- haloperidol (Micromedex) - Includes Dosage Information
- haloperidol Intramuscular (Micromedex) - Includes Dosage Information
- Haloperidol (AHFS DI)
- Haloperidol Decanoate (AHFS DI)
- Haloperidol Lactate (AHFS DI)
- Haloperidol (FDA)
- Haloperidol Decanoate Injection (FDA)
- Haloperidol Oral Solution (FDA)
- Haloperidol Tablets (FDA)
- Haloperidol (Wolters Kluwer)


